ARTBIO
Biotechnology Research
Cambridge, Massachusetts, United States
68 employees
FOR
- Employees
- 68
- Contacts
- 1
- Emails
- 1
ARTBIO Overview
- Headquarters
- Cambridge, Massachusetts, United States
- Website
- www.artbio.com
- Industry
- Biotechnology Research
- Employees
- 68
- Stock Symbol
- FOR
- Funding
- 132.0M
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
About ARTBIO
ARTBIO is a clinical-stage radiopharmaceutical biotechnology company focused on developing a new class of alpha radioligand therapies (ART). Our unique patient-centric approach is underpinned by a deep understanding of cancer biology and the infrastructure needed to effectively design, manufacture, and distribute our therapies.
ARTBIO Contact Details
- People in AeroLeads
- 3
- With contact data
- 1
- Email contacts
- 1
- 33.3% coverage
ARTBIO Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Nikki Hadas | Chief Legal Officer at Artbio | Greater Boston, United States |
View
|
| Emanuele Ostuni | Reinach, Basel-country, Switzerland |
Email
|
|
| Mark Davis | Madison, Wisconsin, United States |
View
|
Compare Similar Companies to ARTBIO
Tessera Therapeutics
Biotechnology Research
KalVista Pharmaceuticals, Inc.
Biotechnology Research
Nuvalent, Inc.
Biotechnology Research
Dyno Therapeutics
Biotechnology Research
Rapport Therapeutics
Biotechnology Research
Arena BioWorks
Biotechnology Research
Fable Therapeutics
Biotechnology Research
Delphia Therapeutics
Biotechnology Research
Myrobalan Therapeutics
Biotechnology Research
Nvelop Therapeutics
Biotechnology Research